
Healthcare · NSE / BSE
Hexagon Nutrition Ltd., established in 1993, is a research-based nutrition company that develops and manufactures a wide range of products including micronutrient premixes, wellness and clinical nutrition products, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing units in India at Nasik, Chennai, and Thoothukudi, along with an international facility in Tashkent, Uzbekistan, with two Indian units located in SEZ areas for better logistics and cost benefits. Its products are divided into three main segments: consumer nutrition products, premix solutions for businesses, and ready-to-use nutrition products under ESG initiatives. The company has a strong distribution network across India through pharmacies, hospitals, e-commerce platforms, and its own brands, supported by over 342 distributors. It also has international offices in South Africa, Uzbekistan, and Hong Kong, exporting products to more than 75 countries. With dedicated R&D facilities and a team of professionals, the company focuses on innovation, and as of July 2025, it has a workforce of 482 employees.
Price Band
₹42 – ₹45
Issue Size
₹3085.97 L Cr
Lot Size
333 shares
GMP
+6.1%
Est. Listing
₹47.75
at current GMP
Subscribed
53.68x
overall
Open
5 Jun 2026
Close
9 Jun 2026
Allotment
10 Jun 2026
Refund
11 Jun 2026
Demat Credit
12 Jun 2026
Listing
12 Jun 2026
Overall Subscription
53.68x
Total Demand
QIB Multiplier
19.77x
Institutions & Funds
NII / HNI
161.49x
High Net-Worth
Retail (RII)
26.85x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 6,172,156 | 122,036,508 | 19.77x |
| NIB | 4,628,956 | 747,541,377 | 161.49x |
| HNIs(10L +) | 3,085,970 | 565,231,203 | 183.16x |
| HNIs (2-10L) | 1,542,985 | 182,310,174 | 118.15x |
| RETAIL | 10,800,896 | 290,035,674 | 26.85x |
| Total | 26,230,963 | 1,907,154,936 | 53.68x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 32,435 | 707,578 | 21.82x |
| HNIs(10L +) | 662 | 24,771 | 37.42x |
| HNIs (2-10L) | 331 | 37,291 | 112.66x |
| Total Applications | 33,428 | 769,640 | 23.02x |
Hexagon Nutrition Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹3,08,59,704 Crores. The shares are offered at a price band of ₹42 to ₹45 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2026-06-09, the basis of allotment is scheduled to be finalized on 2026-06-10. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
The Hexagon Nutrition Limited IPO aggregate issue size is ₹3,08,59,704 Crores with an equity price band set at ₹42 to ₹45 per equity share. The retail lot size is 333 shares requiring a minimum capital outlay of approx. ₹14,985.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. You can track QIB, NII/HNI, and Retail category multiples directly on our dedicated live subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2026-06-10.